Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,582.69
(
0.11%
)
US TECH 100
23,392.00
(
0.08%
)
Dow Jones
46,504.67
(
-0.13%
)
Brent Oil
107.95
(
0.00%
)
Bitcoin
66,794.50
(
-0.74%
)
News Focus
News Focus
Post# of 237
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 467
Posts 26955
Boards Moderated 1
Alias Born 09/11/2006

surf1944

Re: None

Wednesday, 11/18/2009 8:30:10 AM

Wednesday, November 18, 2009 8:30:10 AM

Post# of 237
7:00AM Alnylam Pharma presents new pre-clinical data on ALN-VSP, an RNAi Therapeutic for the treatment of liver cancer (ALNY) 17.44 : Co presented new data that demonstrated robust anti-tumor activity in orthotopic liver tumor models comprised of both HCC- and colorectal cancer-derived cell lines. ALN-VSP was also shown to act on disseminated tumors outside of the liver. Further, in addition to anti-proliferative effects, studies showed that ALN-VSP exerts a potent anti-angiogenic effect on tumors


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ALNY News
More ALNY News